BeOne Medicines (ONC) Total Debt Growth (1y) (2016 - 2026)
Powered by 
Analysis
BeOne Medicines (ONC) Total Debt Growth (1y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | 0.10% |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 12.42% |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | 3.78% |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 0.00% |
| 10 | Incyte | 25.59 Bn | 21.05 Bn | 1.57 Bn | -17.14% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.42% |
| Mar 31, 2026 | 16.78% |
| Dec 31, 2025 | -45.48% |
| Sep 30, 2025 | 133.93% |
| Jun 30, 2025 | -7.95% |
| Mar 31, 2025 | -9.98% |
| Dec 31, 2024 | 111.01% |
| Sep 30, 2024 | 97.97% |
| Jun 30, 2024 | 64.99% |
| Mar 31, 2024 | 110.20% |
| Dec 31, 2023 | 64.65% |
| Sep 30, 2023 | -18.22% |
| Jun 30, 2023 | 11.05% |
| Mar 31, 2023 | -19.85% |
| Dec 31, 2022 | -14.54% |
| Sep 30, 2022 | 0.94% |
| Jun 30, 2022 | -10.12% |
| Mar 31, 2022 | 1.83% |
| Dec 31, 2021 | -26.24% |
| Sep 30, 2021 | 218.81% |